| Literature DB >> 28624296 |
Christopher J Petell1, Gilbert Loiseau2, Ryan Gandy1, Sriharsa Pradhan3, Humaira Gowher4.
Abstract
DNA methylation is a highly conserved epigenetic modification with critical roles ranging from protection against phage infection in bacteria to the regulation of gene expression in mammals. DNA methylation at specific sequences can be measured by using methylation dependent or sensitive restriction enzymes coupled to semi- or quantitative PCR (MD-qPCR). This study reports a refined MD-qPCR method for detecting gain or loss of DNA methylation at specific sites through the specific use of MspJI or HpaII, respectively. By employing varying concentrations of DNA with methylation ranging from 0 to 100%, our data provide evidence that compared to HpaII, MspJI increases the sensitivity and accuracy of detecting relative DNA methylation gains by MD-qPCR. We also show that the MspJI-coupled MD-qPCR can accurately determine the percent gain in DNA methylation at the Sall4 enhancer and is more sensitive than HpaII in detecting relative gains in DNA methylation at the Oct4 proximal enhancer during embryonic stem cell (ESC) differentiation. The high specificity and sensitivity of this targeted approach increases its potential as a diagnostic tool to detect relatively smaller gains in DNA methylation at specific sites from limited amounts of sample.Entities:
Keywords: DNA methylation; HpaII; MD-qPCR; MspJI; Pluripotency gene enhancers; Restriction enzymes
Mesh:
Substances:
Year: 2017 PMID: 28624296 PMCID: PMC5972016 DOI: 10.1016/j.ab.2017.06.006
Source DB: PubMed Journal: Anal Biochem ISSN: 0003-2697 Impact factor: 3.365